Market closedNon-fractional
Smith & Nephew/SN
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1YMAX
About Smith & Nephew
Ticker
SN
Sector
Healthcare
Trading on
LSE
Industry
Health Care Equipment and Supplies
Headquarters
Watford, United Kingdom
Employees
18,452
Website
www.smith-nephew.com
Smith & Nephew Metrics
BasicAdvanced
£9.8B
Market cap
48.08
P/E ratio
£0.23
EPS
0.51
Beta
£0.29
Dividend rate
2.59%
Dividend yield
Price and volume
Market cap
£9.8B
Beta
0.51
Dividend rate
£0.29
Financial strength
Current ratio
1.775
Quick ratio
0.668
Long term debt to equity
44.451
Total debt to equity
59.114
Dividend payout ratio (TTM)
124.33%
Interest coverage (TTM)
5.17%
Management effectiveness
Return on assets (TTM)
4.27%
Return on equity (TTM)
5.02%
Valuation
Price to earnings (TTM)
48.081
Price to revenue (TTM)
2.272
Price to book
1.87
Price to tangible book (TTM)
8.76
Price to free cash flow (TTM)
69.643
Dividend yield (TTM)
2.59%
Growth
Revenue change (TTM)
6.40%
Earnings per share change (TTM)
18.04%
3-year revenue growth (CAGR)
6.76%
3-year earnings per share growth (CAGR)
-16.23%
What the Analysts think about Smith & Nephew
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Smith & Nephew stock.
Smith & Nephew Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Smith & Nephew Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Smith & Nephew News
AllArticlesVideos
Activist Cevian has a stake in medical device company Smith & Nephew. How it may help improve margins
CNBC·2 weeks ago
Activist Investor Takes Stake In Sports Medicine Player Smith & Nephew, Shares Surge
Benzinga·3 weeks ago
Smith & Nephew shares surge as activist Cevian Capital reveals 5% stake
Market Watch·3 weeks ago
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and LSEG
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Smith & Nephew stock?
Smith & Nephew (SN) has a market cap of £9.8B as of July 27, 2024.
What is the P/E ratio for Smith & Nephew stock?
The price to earnings (P/E) ratio for Smith & Nephew (SN) stock is 48.08 as of July 27, 2024.
Does Smith & Nephew stock pay dividends?
Yes, the Smith & Nephew (SN) stock pays dividends to shareholders. As of July 27, 2024, the dividend rate is £0.2915 and the yield is 2.59%. Smith & Nephew has a payout ratio of 124.33% on a trailing twelve-month basis.
When is the next Smith & Nephew dividend payment date?
The next Smith & Nephew (SN) dividend payment date is unconfirmed.
What is the beta indicator for Smith & Nephew?
Smith & Nephew (SN) has a beta rating of 0.51. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Smith & Nephew stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.